GlucosyIeeramide (GIeCer) is a major glycosphingolipid component of epidermis, which is thought to be related to the barrier function of skin permeability. However, the role of glycosphingolipids in keratinocyte growth and differentiation has not been fully clarified. It has been reported that O-threo-l-phenyl-2-decanoylamino-3-morpholino-lpropanol (POMP), an inhibitor of GIeCer synthase (EC 2.4.1.80), depletes cells of glycosphingolipids. This inhibitor has been used as a tool for elucidating their functions. In the present study, the effect of POMP on cultured normal human keratinocytes was investigated. The cells were treated with various concentrations of POMP. Forty-eight hours later cell growth, thymidine incorporation, and lipid content were studied. The cell growth and the incorporation of thymidine into cells were inhibited by POMP in a dose dependent manner. The synthesis of GIeCer was strongly inhibited by POMP treatment, whereas no significant changes in ceramide level were observed. We concluded that GIeCer in epidermis may play an important role in regulating epidermal growth and suggested that POMP may be beneficial for treating proliferative skin disorders in the future.
Introduction
Recently, many studies using normal and transformed cells have shown that glycosphingolipids derived from GlcCer are involved in a range of physiological activities including cell proliferation, cell diferentiation, and apoptosis (1) (2) (3) (4) (5) . These lipids have been proposed to act through regulation of cell kinases, phosphatases, and gene transcription (4, 5) . On the basis of these studies, it is suggested that glycosphingolipids in the epi-dermis might also play an important role in regulating these cellular events.
I t has been reported that D-threo-lphenyl-2-decanoylamino-3-morpholino-lpropanol (PDMP), an inhibitor of GlcCer synthase (EC 2.4.1.80), depletes cells of glycosphingolipids (6) (7) (8) . Therefore, this inhibitor has been used as a tool for elucidating their functions. It has inhibited proliferation of cultured normal cells (9) , has shown chemotherapeutic action in cancer (10, 11) , and has reduced the ability of cancer cells to metastasize (12, 13) . However, the studies of the effects of this GlcCer synthase inhibitor on keratinocytes have been limited (14) . In the present study, we investigated the effect of PDMP on the proliferation and lipid contents of cultured human keratinocytes.
Materials and Methods

Cell Culture
Normal human keratinocytes from healthy
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Fig. 1. Effect of PDMP on Keratinocyte
Growth. The concentrations of PDMP in 11M added to the culture medium are indicated in the figure. Each value indicate the mean ± SD in triplicate wells.
adult skin were cultured using a modification of a previously described method (15) . The cells were grown in keratinocyte growth medium, KGM (Keratinocyte SFM, Gibco, BRL, Grand Island, NY, USA) at 37°C in 5% COj95% air. KGM contained 2.5 ng/ml epidermal growth factor, 35 Ilg/ml bovine pituitary extract, and 0.09 mM CaCI 2 • All experiments were carried out using third or fourth passage keratinocytes grown in KGM as described previously (16) .
Effects ofPDMP on cellproliferation
The stock solution of 1.92 mM PDMP (Biomol Research Laboratories, Inc. PA, USA)-140 mM fatty acid-free bovine serum albumin (Sigma, St. Louis. Mo., USA) complex was prepared as described elsewhere (7) . Cells (4 x 104/well) were seeded into 24-well culture plates (Corning Glass Works, NY, USA) coated with 25 Ilg/ml type IV collagen (Gibco BRL, USA) and incubated at 37°C in 5% CO 2/95% air. Eight hours after seeding, by which time most of the cells had attached to the floor of the well, PDMP (0 to 40 11M in KGM) was added to the wells. Two days and five days later, the wells were washed with PBS, and the cells were dissociated with 0.25% trypsin. Following testing with trypan blue, the number of viable cells was measured using a hemocytemeter.
Effect ofPDMP on DNA synthesis Cells (1 x lOS/well) were seeded into 24-well culture plates coated with type IV collagen and incubated for 24 h at 37°C in 5% CO 2/95% air. After this incubation, cells were exposed for 48 h to various concentrations of PDMP dissolved in KGM. The cells were incubated with 4 IlCi/ml [3H]thymidine (Amersham, Arlington, Ill. USA) for the last 8 h of the PDMP treatment. They were then washed 3 times with PBS. Then 0.5 ml of 1 N NaOH was added to each well, and the sample was counted using a scintilation counter (Beckman, USA).
Reversibility of the PDMP effect on ['H}thymidine incorporation
In order to determine the toxicity of lower concentrations of PDMP, the following study was carried out. Cells were cultivated in a 75 mm" culture dish (Corning Glass Works, NY, USA) coated with type IV collagen as described above and treated with or without 10 11M PDMP in KGM for 48 h. The cells were then washed with PBS 3 times and dissociated with 0.25% trypsin. After centrifugation (500 rpm x 10 min), the cells (1 x lOS/well) were placed in 24-well culture plates coated with type IV collagen and cultured with KGM for another 48 h. For the final 8 hours of the culture, cells were labeled with [3H]thymidine and counted as described above.
Lipid analysis Cells grown in 6-well culture plates (Corning Glass Works, NY, USA) coated with type IV collagen were incubated for 48 hours with or without PDMP. The cells then were washed 3 times with cold PBS and trypsinized. The resultant cell suspension was then centrifuged, and the pellet was fixed with methanol (M). To extract lipids, an equal volume of chloroform (C) was added to each tube, and the tube was sonicated for 15 min in an ultrasonic bath. After centrifuging for 20 min at 2000xg, the pellet was again extracted with a mixture of C:M=I:1 and centrifuged as Each value indicates mean ± SD in triplicate wells. There were no significant differences between the two groups. (Fig. 1) .
Effect of PDMP on [3H]thymidine incorporation
[3H] thymidine incorporation into cells was inhibited by 48 hours of treatment with PDMP in a dose-dependent manner. At the concentration of 5 IJ,M, ['lH] thymidine incorporation was reduced to about 50% of the control level (Fig. 2) .
Reversibility of the PDMP effect on [3H]thymidine incorporation
Cells that were incubated for 48 h in PDMP-free medium after pretreatment with 10 IJ,M of PDMP showed complete recovery (98% of controls) of the ability to incorporate thymidine into cells (Table 1) .
Lipid analysis
GIeCer synthesis was strongly inhibited by 5 IJ,M PDMP ( Table 2 ). The concentration of GIeCer (Ilg/mg protein) was reduced to 14 described above. The resulting supernatants were combined, and 0.9% NaCI was added until the ratio of C:M:NaCI=2:1:0.8 to obtain phase separation. This mixture was vortexed and then centrifuged for 5 min at 800xg. The upper phase was discarded, and lower phase was again mixed with methanol and 0.9% NaCI; the ratio of C:M:aqueous was 2:1:0.8. After centrifugation, the lower phase was transferred to another tube and dried under a stream of nitrogen gas. A part of the dried lipids dissolved in C:M (2:1) was applied to an HPTLC plate (E. Merck silica gel 60). Solvent systems consisting of C:M:W (24:7:1) and C:acetic acid (9:1) were used for GIeCer and Cer analysis, respectively.
Statistical analysis
Each study was triplicated. Non-paired t-analysis was used for the statistical analysis.
Results
Effect ofPDMP on cell proliferation
Cell proliferation was inhibited by PDMP in a dose-dependent manner. Below the concentration of 20 IJ,M, the effect of PDMP was not cytotoxic, and the cell viability was assured by the trypan blue dye exclusion 7 or 8% of the control value. The change in Cer level was not significant after 48 h of treatment with 5 u.M of PDMP.
Discussion
Glycosphingolipids, especially acylGIeCer, have been shown to be major forms of GIeCer in the basal and prickle layers of epidermis and to hydrolyze to ceramide as the cells become horny (17) (18) (19) (20) . The physiological function of GIeCer in basal cells has been unclear; however, recently Holleran et al. indicated that GIeCer serves to stimulate cell proliferation and that its conversion to ceramide as the cells rise toward the skin surface results in differentiation and loss of proliferation (21, 22) . Our results demonstrated that PDMP significantly depleted the GIeCer of cultured human keratinocytes, which are thought to reflect the characteristics of the basal keratinocytes, and inhibited both their growth and [3H]thymidine incorporation. These findings are consistent with the results of previous reports using other cell lines and tissues. However, the mechanism of.the effect ofPDMP and the relationship between GIeCer depletion and growth inhibition are not fully understood. Recently, it has been reported that sphingomyelin breakdown products regulate cell growth, differentiation, and apoptosis (1) (2) (3) (4) (5) . In this metabolic turnover of sphingomyelin, sphingosine and ceramide are thought to have major functional roles. From this point of view, it may be an important question whether GIeCer is the major candidate for the inhibition of cellular growth by PDMP treatment. Using a transformed human keratinocyte cell line, Wakita et al. reported that cell-permeant ceramides inhibited cell growth and induced cell differentiation (3). In our study, by 48 h treatment with PDMP, at which time keratinocyte growth was strongly inhibited, only the GIeCer level was reduced; the change in Cer level was not significant. This result suggests that GIeCer regulates such cellular function by itself. However, it is also possible that changes in the ratio of GIeCer/ Cer related to sphingomyclin metabolism may be a important signal for regulation of keratinocyte function. Further study of the changes in sphingolipid composition by PDMP treatment is needed to clarify the mechanism of PDMP effects. Moreover, it is also important to investigate whether keratinocyte differentiation and apoptosis are induced by PDMP treatment.
PDMP has been expected to be'useful as a new drug in cancer chemotherapy (10, 11) . However, it has not yet been used clinically because its pharmacological safety and toxicity have not been established. If PDMP was administered systemically, the depletion of the cellular GIeCer level must occur in many normal tissues and may result in damage to them (10). However, it is possible that such systemic side effects may be avoided or reduced if PDMP is applied topically. There are many kinds of neoplastic or non-neoplastic proliferative skin disorders. Psoriasis is the most common and benign of these; squamous cell carcinoma is the most common skin cancer. Since PDMP inhibited epidermal cell growth, this substance may have therapeutic value in treating such proliferating skin disorders when applied topically. Our result also suggests that the effect of PDMP is reversible and not toxic at its lower concentration. So it is possible that the toxicity to surrounding normal tissue by PDMP topical application may be less than that resulting from topical chemotherapy using other anti-proliferative ointments such as 5-fluorouracil ointment. Further pharmacological studies are needed to confirm the benefit of PDMP for topical therapy of such skin diseases in the future.
